Previous studies in the NOD model show that IL-17A and IL-17F expression correlates with increased autoimmune-mediated type I diabetes [42] and pharmacological inhibition of Th17 cells prevented the development of diabetes in these mice [43]. Here, IL17A is linked to type 1 diabetes mellitus.